Ronawk is accelerating their T-Block testing program by partnering with commercial cell producers and regenerative medicine technology leaders.
As COVID-19 continues to wage war on the world, researchers in an Olathe-based lab are generating trillions of human cells that could be used to cure the ever-lingering virus.
T-Blocks are changing the way primary stem cells are grown. The technology, owned by the Kansas City-based startup, Ronawk LLC and co-founders A.J. Mellott and Heather Decker, is conducting extensive research on stem cells at the University of Kansas Medical Center.
Ronawk is here to support the drive to rapidly develop effective diagnostic tools, therapies, and vaccines against COVID-19.
Dr. Mellott and Ronawk are accepted into the Class of 2020 Pipeline Fellows.